Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists-Reference-Cited by-同舟云学术

Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists

Published:2012-02-16 Issue:4 Volume:53 Page:e87-e90
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:

Author:

Lamrock Edwina,Brown Pam

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-0960.2011.00863.x/fullpdf

Reference15 articles.

1. Etanercept: an overview of dermatologic adverse events;Lecluse;Arch. Dermatol.,2011

2. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis;Sweiss;Arthritis Rheum.,2005

3. Sarcoidosis occurring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases;Toussirot;Clin. Exp. Rheumatol.,2008

4. Development of sarcoidosis during etanercept therapy;Gonzalez-Lopez;Arthritis Rheum.,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcoidosis;Rook's Textbook of Dermatology;2024-03-19

2. New onset sarcoidosis following biologic treatment in patients with seronegative inflammatory arthritis: A case series and systematic literature review;Autoimmunity Reviews;2024-03

3. Drug-induced Granulomatous Panniculitis: Polarization of M1/M2 Macrophages;Acta Dermato-Venereologica;2023-12-20

4. Onset of Sarcoidosis in Patients on Biologic Therapy: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2022-05-19

5. Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review;BMC Gastroenterology;2021-10-12